New immunosuppressive agents in pediatric transplantation
Clinics
;
69(supl.1): 8-16, 1/2014. tab, graf
Article
in English
| LILACS
| ID: lil-699026
ABSTRACT
Immunosuppressive therapy in pediatrics continues to evolve. Over the past decade, newer immunosuppressive agents have been introduced into adult and pediatric transplant patients with the goal of improving patient and allograft survival. Unfortunately, large-scale randomized clinical trials are not commonly performed in children. The purpose of this review is to discuss the newer immunosuppressive agents available for induction therapy, maintenance immunosuppression, and the treatment of rejection.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Organ Transplantation
/
Graft Rejection
/
Immunosuppressive Agents
Type of study:
Controlled clinical trial
Limits:
Adult
/
Child
/
Humans
Language:
English
Journal:
Clinics
Journal subject:
Medicine
Year:
2014
Type:
Article
Affiliation country:
United States
Institution/Affiliation country:
Children's Hospital of Pittsburgh of UPMC/US
Similar
MEDLINE
...
LILACS
LIS